Yangbo Xing

Dr. Yangbo Xing

Shaoxing People's Hospital

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
BXBuyun Xu
Buyun Xu
YDYe Du
Ye Du
CXChao Xu
Chao Xu
YSYong Sun
Yong Sun
FPFang Peng
Fang Peng
YXYangbo Xing
Yangbo Xing
Background: Left atrial appendage (LAA) morphology predicts stroke risk in patients with atrial fibrillation. However, it is not precisely understood how LAA morphology influences stroke risk. The present study aimed to investigate the relationship between LAA morphology and local thrombogenesis‐related blood parameters in LAA. Methods and Results: We enrolled 205 patients undergoing catheter ablation of atrial fibrillation. The prevalence of chicken wing–, cactus‐, windsock‐, and cauliflower‐type LAAs were 23.9%, 32.7%, 29.3%, and 14.1%, respectively. Blood samples were collected from the femoral vein, left atrium, and LAA in each patient. The levels of blood parameters were tested for each blood sample. The cauliflower‐type LAA was associated with elevated platelet P‐selectin expression, and interleukin‐6 levels and with lower NO levels in LAA blood samples ( P <0.05) independent of LAA flow velocity and LAA volume. LAA flow velocity, which was lowest in the cauliflower‐type LAA, was the only independent predictor of von Willebrand factor antigen and plasminogen activator inhibitor‐1 levels in LAA blood samples. In femoral vein blood samples, no significant difference was detected in the above blood parameters among the four LAA morphological types. In all blood samples, the levels of thrombin‐antithrombin complex, D‐dimer, fibrinogen, and tissue plasminogen activator were comparable among the four LAA morphological types. Conclusions: In patients with atrial fibrillation, LAA morphological types might be associated with local platelet activity, fibrinolysis function, endothelial dysfunction, and inflammation.

1 January 2024 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
YQYinyin Qiu
Yinyin Qiu
LMLiping Meng
Liping Meng
YXYangbo Xing
Yangbo Xing
JPJiahao Peng
Jiahao Peng
YZYan Zhou
Yan Zhou
FPFang Peng
Fang Peng
The incidence and mortality of cardiovascular diseases, of which coronary heart disease (CHD) is a significant cardiovascular burden, are on the rise. Pyroptosis as an incipient programmed cell death mediated by inflammasomes can sense cytoplasmic contamination or interference and is typically marked by intracellular swelling, plasma membrane blistering and intense inflammatory cytokine release. As research on pyroptosis continues to progress, there is mounting evidence that pyroptosis is a vital participant in the pathophysiological basis of CHD. Atherosclerosis is the major pathophysiological basis of CHD and involves pyroptosis of endothelial cells, macrophages, vascular smooth muscle cells, and other immune cells, often in association with the release of pro-inflammatory factors. When cardiomyocytes are damaged, it will eventually lead to heart failure. Previous studies have covered that pyroptosis plays a critical role in CHD. In this review, we describe the properties of pyroptosis, summarize its contribution and related targets to diseases involving angina pectoris, myocardial infarction, myocardial ischemia in perfusion injury and heart failure, and highlight potential drugs for different heart diseases.

7 January 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
JPJie Pan
Jie Pan
CXChao Xu
Chao Xu
BXBuyun Xu
Buyun Xu
YLYuanqing Lou
Yuanqing Lou
SWShengkai Wang
Shengkai Wang
YXYangbo Xing
Yangbo Xing

1 September 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ZYZhangjie Yu
Zhangjie Yu
YXYangbo Xing
Yangbo Xing
JPJiahao Peng
Jiahao Peng
BXBuyun Xu
Buyun Xu
YQYing Qi
Ying Qi
FPFang Peng
Fang Peng
Atrial fibrillation; heart failure; catheter ablation

23 June 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BXBuyun Xu
Buyun Xu
CXChao Xu
Chao Xu
YSYong Sun
Yong Sun
JPJiahao Peng
Jiahao Peng
FPFang Peng
Fang Peng
YXYangbo Xing
Yangbo Xing
In atrial fibrillation (AF) patients, complex electrograms during sinus rhythm (C-EGMs) could be pathological or not. We aimed to demonstrate whether local pacing was helpful to discern pathological C-EGMs. 126 persistent AF patients and 27 patients with left-side accessory pathway (LAP) underwent left atrial mapping during sinus rhythm. If C-EGMs were detected, local pacing was performed. If the electrograms turned normal, we defined them as non-fixed C-EGMs, otherwise as fixed C-EGMs. No difference was detected in the incidence and proportion of non-fixed C-EGMs between AF patients and LAP patients (101/126 vs. 19/27, P = 0.26; 9.1 ± 6.0% vs. 7.7 ± 5.7%, P = 0.28). However, the incidence and proportion of fixed C-EGMs were higher in persistent AF patients (87/126 vs. 1/27, P < 0.01; 4.3 ± 3.4% vs. 0.1 ± 0.5%, P < 0.01). Compared with non-fixed C-EGMs, fixed C-EGMs had lower amplitudes, longer electrogram durations and longer Stimuli-P wave internals. All AF patients received circumferential pulmonary vein isolation. Among AF patients with fixed C-EGMs, 45 patients received fixed C-EGMs ablation and 42 patients underwent linear ablation. Compared with linear ablation, fixed C-EGMs ablation reduced recurrence (HR: 0.43; 95% CI 0.21‐0.81; P = 0.011). Among patients without fixed C-EGMs ablation, the proportion of fixed C-EGMs was an independent predictor of ablation outcomes (HR for per percent: 1.13, 95% CI 1.01–1.28, P = 0.038). C-EGMs could be classified into fixed and non-fixed C-EGMs through local pacing. Fixed rather than non-fixed C-EGMs might indicate abnormal atrial substrates and fixed C-EGMs ablation improve outcomes of persistent AF ablation.